Table 1 Characteristics of eligible studies for prognosis
Study | Year | Country | Tumor type | Sample size | Detection method | Survival analysis | Analysis type | Source of HR | NOS score |
|---|---|---|---|---|---|---|---|---|---|
Ajona et al. | 2018 | Spain | NSCLC | 75 | IHC | OS, RFS | Multivariate | Reported | 8 |
Kaida et al. | 2016 | Japan | GC | 100 | IHC | OS | Multivariate | Reported | 8 |
Wada et al. | 2016 | Japan | UCC | 52 | IHC | OS | Multivariate | Reported | 7 |
Xi et al. | 2016 | China | RCC | 272 | IHC | OS, RFS | Multivariate | Reported | 9 |
Nitta et al. | 2016 | Japan | GC | 148 | IHC | OS, RFS | Multivariate | Survival Curve | 9 |
Imamura et al. | 2015 | Japan | BC | 171 | IHC | OS, RFS | Multivariate | Reported | 8 |
Gu et al. | 2013 | China | NSCLC | 208 | IHC | OS | Multivariate | Reported | 8 |